Please login to the form below
Cello Health BioConsulting appoints Jim Hall as president
Senior pharma marketer to preside over newly-formed consulting firm
Cello Health BioConsulting has appointed senior pharma marketer Jim Hall as president.
Hall joins with over 20 years of experience in the life sciences industry and, prior to joining Cello Health BioConsulting, was senior VP of Campbell Alliance's Corporate Development Practice and senior partner at Oliver Wyman in the health and life science practice.
Jon Bircher, global CEO of Cello Health consulting, said: “Jim brings an unparalleled knowledge and understanding of the US and global market, of great quality consulting and is the perfect person to lead the bioconsulting team, helping expand Cello Health's footprint in the United States and beyond.”
Julia Ralston, CEO of Cello Health US, added: “He will drive our expansion, not only working with our growing team of strong consultants as leading advisors to the bio-pharmaceutical and healthcare sector, but also contributing to our overarching Cello Health strategy.”
Hall will be based at the firm's Boston office and is the second recent hire for Cello Health BioConsulting.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Medical Editor
-
Competitive
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- COVID-19 vaccine developers respond to new strain
- Experimental Chinese COVID-19 vaccine is safe, according to researchers
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
